Glenmark Life Sciences Ltd
NSE:GLS
Intrinsic Value
The intrinsic value of one GLS stock under the Base Case scenario is 718.3 INR. Compared to the current market price of 1 100.6 INR, Glenmark Life Sciences Ltd is Overvalued by 35%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Glenmark Life Sciences Ltd
Fundamental Analysis

Revenue & Expenses Breakdown
Glenmark Life Sciences Ltd
Balance Sheet Decomposition
Glenmark Life Sciences Ltd
Current Assets | 21B |
Cash & Short-Term Investments | 5.3B |
Receivables | 7.8B |
Other Current Assets | 7.9B |
Non-Current Assets | 9.9B |
Long-Term Investments | 111.2m |
PP&E | 9.5B |
Intangibles | 172.7m |
Other Non-Current Assets | 152.9m |
Free Cash Flow Analysis
Glenmark Life Sciences Ltd
INR | |
Free Cash Flow | INR |
Earnings Waterfall
Glenmark Life Sciences Ltd
Revenue
|
22B
INR
|
Cost of Revenue
|
-9.9B
INR
|
Gross Profit
|
12.1B
INR
|
Operating Expenses
|
-6.6B
INR
|
Operating Income
|
5.5B
INR
|
Other Expenses
|
-1.3B
INR
|
Net Income
|
4.2B
INR
|
GLS Profitability Score
Profitability Due Diligence
Glenmark Life Sciences Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
Score
Glenmark Life Sciences Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
GLS Solvency Score
Solvency Due Diligence
Glenmark Life Sciences Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
Glenmark Life Sciences Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GLS Price Targets Summary
Glenmark Life Sciences Ltd
According to Wall Street analysts, the average 1-year price target for GLS is 1 214.41 INR with a low forecast of 797.9 INR and a high forecast of 1 428 INR.
Dividends
Current shareholder yield for GLS is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one GLS stock under the Base Case scenario is 718.3 INR.
Compared to the current market price of 1 100.6 INR, Glenmark Life Sciences Ltd is Overvalued by 35%.